CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date needs a touch-up? - you are welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute
Read more about CAZypedia here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.

Difference between revisions of "Glycoside Hydrolase Family 84"

From CAZypedia
Jump to navigation Jump to search
Line 30: Line 30:
 
== Substrate specificities ==
 
== Substrate specificities ==
  
In contrast to the ''b''-hexosaminidases of GH20 a relaxed specificity for substitutions of the ''N''-acyl group is observed with residues significantly more bulky than the ''N''-acyl group being tolerated.REF
+
GH84 contains ''β''-''N''-acetylglucosaminidases and ''β''-''N''-acetylhyaluronidase activities. Human O-GlcNAcase is a cytosolic enzyme whose ''in vivo'' targets are glycoprotein serine and threonine residues modified by a single ''β''-linked GlcNAc residue.  In contrast to the ''β''-hexosaminidases of GH20 a relaxed specificity for substitutions of the ''N''-acyl group is observed with residues significantly more bulky than the ''N''-acyl group being tolerated.<cite>DJV2005</cite>
Content is to be added here.
 
 
 
This is an example of how to make references to a journal article <cite>Comfort2007</cite>. (See the References section below).  Multiple references can go in the same place like this <cite>Comfort2007 He1999</cite>.  You can even cite books using just the ISBN <cite>3</cite>.  References that are not in PubMed can be typed in by hand <cite>MikesClassic</cite>. 
 
  
  
 
== Kinetics and Mechanism ==
 
== Kinetics and Mechanism ==
The most extensive kinetic studies have been carried out on Human ''O''-GlcNAcase. Neighbouring group participation.<cite>DJV2005</cite> Substrate distortion.<cite>DJV2009 DJV2010</cite> General acid catalysis operative for substrates possessing leaving groups with pKas greater than approximately XXX. For either ''O''- or ''S''-glycosides possessing leaving groups with pKas below XXX the leaving group will depart at the anion.<cite>DJV2005Thio DJV2009</cite> Nuclear isoform (TRUNCATION) of Human O-GlcNAcase retains similar kinetic properties and inhibitory patterns as the cytosolic isoform consistent with hexosaminidase activity residing in the XXX domains.<cite>DJV2009Trunc</cite>
+
Members of GH84 utilize a mechanism of neighbouring group participation, originally established through the use of free-energy relationships.<cite>DJV2005</cite> The most extensive kinetic studies have been carried out on human ''O''-GlcNAcase. Substrate distortion.<cite>DJV2009 DJV2010</cite> General acid catalysis operative for substrates possessing leaving groups with pKas greater than approximately XXX. For either ''O''- or ''S''-glycosides possessing leaving groups with pKas below XXX the leaving group will depart at the anion.<cite>DJV2005Thio DJV2009</cite> Nuclear isoform (TRUNCATION) of Human O-GlcNAcase retains similar kinetic properties and inhibitory patterns as the cytosolic isoform consistent with hexosaminidase activity residing in the XXX domains.<cite>DJV2009Trunc</cite>
  
  
Line 55: Line 52:
  
 
== Family Firsts ==
 
== Family Firsts ==
;First sterochemistry determination: Cite some reference here, with a ''short'' (1-2 sentence) explanation <cite>Comfort2007</cite>.
+
;First sterochemistry determination: <sup>1</sup>H-NMR studies of human O-GlcNAcase established that the ''β''-configured hemiacetal product is formed prior to anomerisation.<cite>DJV2009</cite>.
 
;First catalytic nucleophile identification: Cite some reference here, with a ''short'' (1-2 sentence) explanation <cite>MikesClassic</cite>.
 
;First catalytic nucleophile identification: Cite some reference here, with a ''short'' (1-2 sentence) explanation <cite>MikesClassic</cite>.
;First general acid/base residue identification: Cite some reference here, with a ''short'' (1-2 sentence) explanation <cite>He1999</cite>.
+
;First general acid/base residue identification: Studies of human O-GlcNAcase mutant Asp175Ala identify reactivity patterns (free energy relationships, pH-activity profiles) consistent with the action of Asp175 as the catalytic general acid/base.<cite>DJV2006</cite>.
;First 3-D structure: Cite some reference here, with a ''short'' (1-2 sentence) explanation <cite>3</cite>.
+
;First 3-D structure: The structures of ''Bacteroides thetaiotaomicron'' O-GlcNAcase<cite>GJD2006</cite> and ''Clostridium perfringens'' NagJ<cite>DvA2006</cite>.
  
 
== References ==
 
== References ==

Revision as of 15:26, 6 December 2010

Under construction icon-blue-48px.png

This page is currently under construction. This means that the Responsible Curator has deemed that the page's content is not quite up to CAZypedia's standards for full public consumption. All information should be considered to be under revision and may be subject to major changes.


Glycoside Hydrolase Family GH84
Clan none
Mechanism retaining
Active site residues known
CAZy DB link
http://www.cazy.org/GH84.html


Substrate specificities

GH84 contains β-N-acetylglucosaminidases and β-N-acetylhyaluronidase activities. Human O-GlcNAcase is a cytosolic enzyme whose in vivo targets are glycoprotein serine and threonine residues modified by a single β-linked GlcNAc residue. In contrast to the β-hexosaminidases of GH20 a relaxed specificity for substitutions of the N-acyl group is observed with residues significantly more bulky than the N-acyl group being tolerated.[1]


Kinetics and Mechanism

Members of GH84 utilize a mechanism of neighbouring group participation, originally established through the use of free-energy relationships.[1] The most extensive kinetic studies have been carried out on human O-GlcNAcase. Substrate distortion.[2, 3] General acid catalysis operative for substrates possessing leaving groups with pKas greater than approximately XXX. For either O- or S-glycosides possessing leaving groups with pKas below XXX the leaving group will depart at the anion.[2, 4] Nuclear isoform (TRUNCATION) of Human O-GlcNAcase retains similar kinetic properties and inhibitory patterns as the cytosolic isoform consistent with hexosaminidase activity residing in the XXX domains.[5]


Catalytic Residues

Studies of two mutants of human O-GlcNAcase established that adjacent aspartate residues, Asp174 and Asp175, act as critical components of the catalytic machinery of this enzyme.[6]

The mutant Asp175Ala displayed marked reductions in activity (V and (V/K)) towards aryl N-acetylglucosaminides possessing poor leaving groups with smaller reductions being observed for both O-aryl and S-aryl N-acetylglucosaminides substrates possessing better leaving groups. Exogenous azide was found to partially rescue the activity of human O-GlcNAcase towards 3,4-dinitrophenylglucosaminide. These results identify Asp175 as the general acid catalyst.

The mutant Asp174Ala showed decreased activity towards O-aryl N-acetylglucosaminides possessing good leaving groups and it was argued that this is consistent with its role as a residue responsible for the orientation and polarization of the N-acyl nucleophile.


Three-dimensional structures

The reported crystallization of Clostridium perfringens NagJ[7] was followed by solved structures for that enzyme[8] and Bacteroides thetaiotaomicron b-hexosaminidase[8]. A series of crystallographic studies on Bacteroides thetaiotaomicron b-hexosaminidase using a variety of small molecules define the conformational itinerary for this family. Substrate distortion: WT + azepane [9], WT + difluoroacetyl [10], 4C1 intermediate: WT + thiazoline [1], general acid mutants Asp243Asn + 5-fluorooxazoline derived from b-1,5-difluoroglucosaminide,[10] Asp243Asn + oxazoline derived from 4-methylumbelliferyl b-glucosaminide,[10].


Family Firsts

First sterochemistry determination
1H-NMR studies of human O-GlcNAcase established that the β-configured hemiacetal product is formed prior to anomerisation.[2].
First catalytic nucleophile identification
Cite some reference here, with a short (1-2 sentence) explanation [11].
First general acid/base residue identification
Studies of human O-GlcNAcase mutant Asp175Ala identify reactivity patterns (free energy relationships, pH-activity profiles) consistent with the action of Asp175 as the catalytic general acid/base.[6].
First 3-D structure
The structures of Bacteroides thetaiotaomicron O-GlcNAcase[12] and Clostridium perfringens NagJ[8].

References

  1. Macauley MS, Whitworth GE, Debowski AW, Chin D, and Vocadlo DJ. (2005). O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem. 2005;280(27):25313-22. DOI:10.1074/jbc.M413819200 | PubMed ID:15795231 [DJV2005]
  2. Greig IR, Macauley MS, Williams IH, and Vocadlo DJ. (2009). Probing synergy between two catalytic strategies in the glycoside hydrolase O-GlcNAcase using multiple linear free energy relationships. J Am Chem Soc. 2009;131(37):13415-22. DOI:10.1021/ja904506u | PubMed ID:19715310 [DJV2009]
  3. He Y, Macauley MS, Stubbs KA, Vocadlo DJ, and Davies GJ. (2010). Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J Am Chem Soc. 2010;132(6):1807-9. DOI:10.1021/ja9086769 | PubMed ID:20067256 [DJV2010]
  4. Macauley MS, Stubbs KA, and Vocadlo DJ. (2005). O-GlcNAcase catalyzes cleavage of thioglycosides without general acid catalysis. J Am Chem Soc. 2005;127(49):17202-3. DOI:10.1021/ja0567687 | PubMed ID:16332065 [DJV2005Thio]
  5. Macauley MS and Vocadlo DJ. (2009). Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase. Carbohydr Res. 2009;344(9):1079-84. DOI:10.1016/j.carres.2009.04.017 | PubMed ID:19423084 [DJV2009Trunc]
  6. Cetinbaş N, Macauley MS, Stubbs KA, Drapala R, Vocadlo DJ. Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants. Biochemistry. 2006 Mar 21;45(11):3835-44.

    [DJV2006]

    Note: Due to a problem with PubMed data, this reference is not automatically formatted. Please see these links out: DOI:10.1021/bi052370b PMID:16533067

  7. Ficko-Blean E and Boraston AB. (2005). Cloning, recombinant production, crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase from Clostridium perfringens. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005;61(Pt 9):834-6. DOI:10.1107/S1744309105024012 | PubMed ID:16511172 [ABB2005]
  8. Rao FV, Dorfmueller HC, Villa F, Allwood M, Eggleston IM, and van Aalten DM. (2006). Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J. 2006;25(7):1569-78. DOI:10.1038/sj.emboj.7601026 | PubMed ID:16541109 [DvA2006]
  9. Marcelo F, He Y, Yuzwa SA, Nieto L, Jiménez-Barbero J, Sollogoub M, Vocadlo DJ, Davies GD, and Blériot Y. (2009). Molecular basis for inhibition of GH84 glycoside hydrolases by substituted azepanes: conformational flexibility enables probing of substrate distortion. J Am Chem Soc. 2009;131(15):5390-2. DOI:10.1021/ja809776r | PubMed ID:19331390 [Ble2009]
  10. He Y, Macauley MS, Stubbs KA, Vocadlo DJ, and Davies GJ. (2010). Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J Am Chem Soc. 2010;132(6):1807-9. DOI:10.1021/ja9086769 | PubMed ID:20067256 [GJD2010]
  11. Sinnott, M.L. (1990) Catalytic mechanisms of enzymic glycosyl transfer. Chem. Rev. 90, 1171-1202. DOI: 10.1021/cr00105a006

    [MikesClassic]
  12. Dennis RJ, Taylor EJ, Macauley MS, Stubbs KA, Turkenburg JP, Hart SJ, Black GN, Vocadlo DJ, and Davies GJ. (2006). Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity. Nat Struct Mol Biol. 2006;13(4):365-71. DOI:10.1038/nsmb1079 | PubMed ID:16565725 [GJD2006]
  13. Comfort DA, Bobrov KS, Ivanen DR, Shabalin KA, Harris JM, Kulminskaya AA, Brumer H, and Kelly RM. (2007). Biochemical analysis of Thermotoga maritima GH36 alpha-galactosidase (TmGalA) confirms the mechanistic commonality of clan GH-D glycoside hydrolases. Biochemistry. 2007;46(11):3319-30. DOI:10.1021/bi061521n | PubMed ID:17323919 [Comfort2007]
  14. He S and Withers SG. (1997). Assignment of sweet almond beta-glucosidase as a family 1 glycosidase and identification of its active site nucleophile. J Biol Chem. 1997;272(40):24864-7. DOI:10.1074/jbc.272.40.24864 | PubMed ID:9312086 [He1999]
  15. Robert V. Stick and Spencer J. Williams. (2009) Carbohydrates. Elsevier Science. [3]

All Medline abstracts: PubMed